Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance
LDN blocks opioid receptors, flooding your body with endorphins to enhance healing, promote weight loss, and boost overall vitality—unleashing the new you.
Wegovy® (semaglutide) is an FDA-approved prescription medication used for chronic weight management in adults with obesity or excess weight. It belongs to a class of medications called GLP-1 receptor agonists.
Wegovy® works by mimicking a natural hormone in your body that helps regulate appetite and blood sugar, which can support reduced food intake and healthier eating patterns when combined with lifestyle changes.
Wegovy® has been clinically studied for weight management. In clinical trials, adults who used Wegovy® alongside diet and lifestyle changes lost an average of 14–15% of their body weight over one year.*
Individual results vary based on factors such as dosage, adherence, lifestyle habits, and overall health.
Both the Wegovy® pill and the Wegovy® pen contain the same active ingredient, semaglutide, and are FDA-approved for weight management. The main difference is how and how often they’re taken.
Similarities:
Differences:
Your Shed provider will help determine which option may be appropriate based on your health history, preferences, and treatment goals.
Both medications contain semaglutide, but they are FDA-approved for different uses.
In some cases, providers may prescribe Ozempic® off-label for weight management when appropriate, but Wegovy® is the formulation designed and approved for weight loss.






Wegovy® is now available as a once-daily pill, offering a needle-free option for people who prefer oral medication. Like the Wegovy® pen, the pill contains semaglutide and is FDA-approved for chronic weight management.
This new delivery method gives patients more flexibility in how they take Wegovy®, while still receiving provider-guided care through Shed.

*In clinical trials of Wegovy® (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise. This compares to approximately 2–3% weight loss with diet and exercise alone.

















Wegovy® (semaglutide) is an FDA-approved prescription medication used for chronic weight management in adults with obesity or excess weight. It belongs to a class of medications called GLP-1 receptor agonists.
Wegovy® works by mimicking a natural hormone in your body that helps regulate appetite and blood sugar, which can support reduced food intake and healthier eating patterns when combined with lifestyle changes.
Wegovy® has been clinically studied for weight management. In clinical trials, adults who used Wegovy® alongside diet and lifestyle changes lost an average of 14–15% of their body weight over one year.*
Individual results vary based on factors such as dosage, adherence, lifestyle habits, and overall health.
Both the Wegovy® pill and the Wegovy® pen contain the same active ingredient, semaglutide, and are FDA-approved for weight management. The main difference is how and how often they’re taken.Similarities:
Differences:
Your Shed provider will help determine which option may be appropriate based on your health history, preferences, and treatment goals.
Both medications contain semaglutide, but they are FDA-approved for different uses.
In some cases, providers may prescribe Ozempic® off-label for weight management when appropriate, but Wegovy® is the formulation designed and approved for weight loss.
Shed provides access to Wegovy® through a fully online, provider-led care model.
If prescribed, your program includes:
Medication costs are separate from the monthly Shed membership.




LDN blocks opioid receptors, flooding your body with endorphins to enhance healing, promote weight loss, and boost overall vitality—unleashing the new you.




LDN blocks opioid receptors, flooding your body with endorphins to enhance healing, promote weight loss, and boost overall vitality—unleashing the new you.







Doctor of Medicine (MD),
Internal Medicine Physician
While GLP-1 microdosing is ideal for maintenance, longevity, and overall wellness support, those with a significant weight-loss goal may be better suited for a standard GLP-1 dose.






Compounded medications are prepared by licensed pharmacies to meet individual patient needs. While they are not reviewed or approved by the FDA for safety or effectiveness, they are made in accordance with strict regulatory guidelines. Prescription is only available after consultation with a licensed provider to determine if treatment is appropriate.
Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance